Evidence map›Paper›PMID 38866484›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2024

Arachidonic Acid Mobilization and Peroxidation Promote Microglial Dysfunction in Aβ Pathology.

Da Lin, Andrew Gold, Sarah Kaye, Jeffrey R Atkinson, Marcus Tol, Andrew Sas, Benjamin Segal, Peter Tontonoz, Jiangjiang Zhu, Jie Gao

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Prediction of cognitive outcome and progression to dementia using ω6-PUFA/ω3-PUFA ratio.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Da LinDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Andrew GoldDepartment of Human Sciences, The Ohio State University, Columbus, Ohio 43210.
Sarah KayeDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Jeffrey R AtkinsonDepartment of Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Marcus TolDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095.
Andrew SasDepartment of Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Benjamin SegalDepartment of Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Peter TontonozDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095.
Jiangjiang ZhuDepartment of Human Sciences, The Ohio State University, Columbus, Ohio 43210.
Jie GaoDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210 Jie.Gao@osumc.edu.ORCID 0000-0001-5448-6606

Funding

Targeting IDOL-ApoE receptor pathway in Alzheimer's diseaseR01AG073310 · NIA · OHIO STATE UNIVERSITY · PI Jie Gao · 2022 to 2026
$2.7M
Characterizing the Metabolome and Volatilome of Gut MicrobiomeR35GM133510 · NIGMS · OHIO STATE UNIVERSITY · PI ZHU, JIANGJIANG · 2019 to 2023
$2.2M
Neutrophil driven recovery from traumatic and ischemic optic neuropathyK08EY029362 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SAS, ANDREW ROBERT · 2018 to 2022
$898k
Mapping protein interactome of TREM2 and its variants to probe the etiology of Alzheimer's DiseaseR21AG075875 · NIA · OHIO STATE UNIVERSITY · PI GAO, JIE · 2022 to 2023
$433k
NEI NIH HHS K08 EY029362NEI NIH HHS L40 EY029522NIA NIH HHS R01 AG073310NIA NIH HHS R21 AG075875NIGMS NIH HHS R35 GM133510
6 · The paper itself

Abstract

Aberrant increase of arachidonic acid (ARA) has long been implicated in the pathology of Alzheimer's disease (AD), while the underlying causal mechanism remains unclear. In this study, we revealed a link between ARA mobilization and microglial dysfunction in Aβ pathology. Lipidomic analysis of primary microglia from App

Indexed as

1-Acylglycerophosphocholine O-AcyltransferaseAmyloid beta-PeptidesArachidonic AcidMicrogliaAlzheimer DiseaseAnimalsFemaleLipid PeroxidationMaleMiceMice, Inbred C57BLMice, TransgenicOxidative StressPhospholipids1-Acylglycerophosphocholine O-AcyltransferaseAmyloid beta-PeptidesArachidonic AcidLPCAT3 protein, mousePhospholipidsAlzheimer's diseasearachidonic acidlipid peroxidationLPCAT3microglial dysfunctionoxidative stress

Identifiers

PMID38866484
PMCPMC11293449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.